10172017Headline:

Little Rock, Arkansas

HomeArkansasLittle Rock

Email Frank Bailey Frank Bailey on LinkedIn Frank Bailey on Twitter Frank Bailey on Facebook
Frank Bailey
Frank Bailey
Contributor •

Zetia May Cause Liver Damage

Comments Off

Are big drug companies hiding the results of unfavorable test in favor of profits? A recent article in the New York Times seems to indicate that is just what is happening. The New York Times writes:
New evidence shows that the drug makers Merck and Schering-Plough have conducted several studies of their popular cholesterol medicine Zetia that raise questions about its risks to the liver, but the companies have never published those results.

Partial results of the studies, alluded to in documents on the Food and Drug Administration’s Web site, raise questions about whether Zetia can cause liver damage when used long term with other cholesterol drugs called statins.

Most of the millions of people who use Zetia take it along with a statin like Lipitor, Crestor or Zocor. Or they take it in a single pill, Vytorin, that combines Zetia with Zocor.
The discovery of the unpublished research comes as Merck and Schering are already under criticism for not yet releasing data from an important Zetia study, called Enhance, that they completed early last year.

Trial attorneys are working every day to make big drug companies meet their responsibility to the American public. If we as Americans do not come forward and demand truthfulness from big drug companies we will see the drug companies and their defense lawyers congratulating each other for having permanently escaped responsibility yet another time.